| Angelia Smith Natili, MD | |
|
707 Bryant St, Statesville, NC 28677-4142 | |
| (704) 873-5224 | |
| Not Available |
| Full Name | Angelia Smith Natili |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 15 Years |
| Location | 707 Bryant St, Statesville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831406933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | BP10037973 (Texas) | Secondary |
| 207Y00000X | Otolaryngology | 2015-00328 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Iredell Memorial Hospital Inc | Statesville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Healthcare Pa | 9638070683 | 222 |
News Archive
The risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat, meaning that a large portion of the population has an unrecognized risk of developing cancer.
Natural genetic changes can put some people at high risk of certain conditions, such as breast cancer, Alzheimer's disease or high blood pressure. But in rare cases, genetic errors also can have the opposite effect, protecting individuals with these helpful genetic mistakes from developing common diseases.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, is delighted to announce that its Advanced Projects Group has partnered with a leading pharma company to successfully design and deliver Sonata™, a unique system for automated culturing and processing of cell lines in shake flasks.
› Verified 5 days ago
| Entity Name | Piedmont Healthcare Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912999897 PECOS PAC ID: 9638070683 Enrollment ID: O20040114000339 |
News Archive
The risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat, meaning that a large portion of the population has an unrecognized risk of developing cancer.
Natural genetic changes can put some people at high risk of certain conditions, such as breast cancer, Alzheimer's disease or high blood pressure. But in rare cases, genetic errors also can have the opposite effect, protecting individuals with these helpful genetic mistakes from developing common diseases.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, is delighted to announce that its Advanced Projects Group has partnered with a leading pharma company to successfully design and deliver Sonata™, a unique system for automated culturing and processing of cell lines in shake flasks.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angelia Smith Natili, MD 707 Bryant St, Statesville, NC 28677-4142 Ph: (704) 873-5224 | Angelia Smith Natili, MD 707 Bryant St, Statesville, NC 28677-4142 Ph: (704) 873-5224 |
News Archive
The risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat, meaning that a large portion of the population has an unrecognized risk of developing cancer.
Natural genetic changes can put some people at high risk of certain conditions, such as breast cancer, Alzheimer's disease or high blood pressure. But in rare cases, genetic errors also can have the opposite effect, protecting individuals with these helpful genetic mistakes from developing common diseases.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, is delighted to announce that its Advanced Projects Group has partnered with a leading pharma company to successfully design and deliver Sonata™, a unique system for automated culturing and processing of cell lines in shake flasks.
› Verified 5 days ago
Mark L Prendergast, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 707 Bryant St, Statesville, NC 28677 Phone: 704-873-5224 | |
Alan E Deddens, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 707 Bryant St, Statesville, NC 28677 Phone: 704-873-5224 | |
Steven Jay Landau, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 707 Bryant St, Statesville, NC 28677 Phone: 704-873-5224 | |
Ronel Rocha Enrique, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 556 Kitchings Dr, Statesville, NC 28677 Phone: 704-838-8255 |